Clover Health Investments, Corp. (NASDAQ:CLOV) Short Interest Down 31.6% in August

Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report) saw a large decrease in short interest during the month of August. As of August 31st, there was short interest totalling 20,090,000 shares, a decrease of 31.6% from the August 15th total of 29,360,000 shares. Based on an average daily trading volume, of 7,600,000 shares, the short-interest ratio is currently 2.6 days.

Hedge Funds Weigh In On Clover Health Investments

Several large investors have recently modified their holdings of CLOV. Viewpoint Capital Management LLC increased its holdings in Clover Health Investments by 96.8% in the second quarter. Viewpoint Capital Management LLC now owns 30,500 shares of the company's stock valued at $38,000 after buying an additional 15,000 shares during the last quarter. Vanguard Personalized Indexing Management LLC raised its position in shares of Clover Health Investments by 54.4% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 34,372 shares of the company's stock valued at $42,000 after acquiring an additional 12,104 shares in the last quarter. Marshall Wace LLP bought a new position in Clover Health Investments during the second quarter worth $55,000. Jaffetilchin Investment Partners LLC boosted its holdings in Clover Health Investments by 30.2% in the first quarter. Jaffetilchin Investment Partners LLC now owns 49,741 shares of the company's stock worth $39,000 after purchasing an additional 11,550 shares during the period. Finally, Allspring Global Investments Holdings LLC increased its stake in Clover Health Investments by 151.2% during the first quarter. Allspring Global Investments Holdings LLC now owns 77,948 shares of the company's stock valued at $62,000 after purchasing an additional 46,912 shares during the last quarter. Institutional investors own 19.77% of the company's stock.

Clover Health Investments Trading Up 7.9 %

NASDAQ CLOV traded up $0.22 during mid-day trading on Friday, reaching $2.99. 5,581,891 shares of the company's stock traded hands, compared to its average volume of 8,010,894. The company has a fifty day simple moving average of $2.24 and a 200-day simple moving average of $1.37. Clover Health Investments has a 1-year low of $0.61 and a 1-year high of $3.82. The company has a market cap of $1.48 billion, a price-to-earnings ratio of -8.79 and a beta of 2.13.

Clover Health Investments (NASDAQ:CLOV - Get Free Report) last issued its quarterly earnings results on Monday, August 5th. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.04) by $0.05. Clover Health Investments had a negative net margin of 7.30% and a negative return on equity of 36.55%. The business had revenue of $356.26 million during the quarter, compared to analyst estimates of $338.70 million. During the same quarter in the previous year, the firm earned ($0.06) earnings per share. Equities research analysts forecast that Clover Health Investments will post -0.13 earnings per share for the current fiscal year.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.